SUBSCRIBE
SUBSCRIBE
News   FDA

Japan Approves Eisai Company, Ltd.'s Drug Aricept for Severe Alzheimer’s

August 23, 2007 | 
1 min read
TOKYO, Aug 23 (Reuters) - Eisai Co Ltd said on Thursday its top-selling Alzheimer's drug Aricept has been approved to treat the late stage of the disease in Japan, the world's second-biggest drug market.
FDA Approvals Asia
MORE ON THIS TOPIC
Regulatory
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator
October 7, 2025
 · 
1 min read
 · 
Heather McKenzie
Traffic light silhouette and golden sky.
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
October 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Space rocket crashed and on fire. Business failure, failed startup. Downfall of ambitious plans, flawed execution, or crisis outcomes. Volatility of startups, financial risks, or unexpected setbacks.
Gene therapy
Rocket Aborts FDA Filing for Rare Blood Disease Gene Therapy
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac